🔎 Trials Near Me

Akèy › Kolit Ulseratif › Massachusetts › Boston

Etid klinik pou Kolit Ulseratif nan Boston, MA

12 etid pou Kolit Ulseratif ap chèche patisipan nan sit nan ak bò kote Boston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 003, Boston
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

Ap rekriteFaz 2/3
  • Boston Children's Hospital, Boston
Laj 2 a 17 · Tout sèks · Mizajou Sep 24, 2026 · NCT05076175

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345

LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:

Ap rekriteFaz 2
  • Brigham and Women's Hospital, Boston
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07186101

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Ap rekriteFaz 3
  • Boston Children's Hospital, Boston
Laj 2 a 19 · Tout sèks · Mizajou Sep 22, 2026 · NCT04844606

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 3
  • Tufts Medical Center - Site Number: 8400126, Boston
Laj 16 a 80 · Tout sèks · Mizajou Aug 20, 2026 · NCT07184996

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ap rekriteEtid obsèvasyon
  • Brigham and Women's Hospital, Boston
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07237516

A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Ap rekriteFaz 2
  • Boston Children's Hospital, Boston
Laj 12 a 17 · Tout sèks · Mizajou Jul 8, 2026 · NCT05287126

A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis

Ap rekriteFaz 2
  • Investigational Site Number: 8400017, Boston
Laj 18 a 75 · Tout sèks · Mizajou Apr 23, 2026 · NCT06975722

Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)

Ap rekrite
  • Massachusetts General Hospital, Boston
Laj 18 a 85 · Tout sèks · Mizajou Jan 8, 2026 · NCT05987852

High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy

Ap rekriteEtid obsèvasyon
  • Boston Children's Hospital, Boston
Laj 5 a 25 · Tout sèks · Mizajou Mar 3, 2025 · NCT04331639

Family Members At INcreased-risk for Developing Inflammatory Bowel Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Massachusetts General Hospital, Boston
Laj 14 ak plis · Tout sèks · Mizajou Dec 20, 2024 · NCT06655415

Etid Kolit Ulseratif nan lòt vil

Lòt etid nan Boston

Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.